Statin Therapy
Primary Prevention- No Diabetes and LDL-C <190 mg/dL
Primary Prevention- Diabetes
High-dose statins after minor stroke tied to hemorrhage risk in a Chinese cohort
Initiation of high-intensity statin therapy during the acute phase of minor, noncardiogenic stroke may increase bleeding risk, according to the results of a Chinese cohort study published in the Journal of the American Heart Association.
Statin use when not indicated for certain strokes could cause adverse events
Statin initiation in patients with stroke etiologies not indicated for secondary prevention with statin therapy could hypothetically cause thousands of adverse events every year, according to a new meta-analysis published in Stroke.
Icosapent ethyl ‘could have relevance’ for lowering CV risk in adults with CAD on statins
Icosapent ethyl significantly reduced coronary events and led to numerically fewer CV events at 5 years for patients with CAD and low plasma eicosapentaenoic acid already taking statin therapy, researchers reported.
NLA document issued to optimize screening, management of lipids in reproductive-age women
The National Lipid Association has issued a clinical consensus statement on the management of dyslipidemia in women of reproductive potential, with a focus on considerations for pharmacologic options, a speaker reported.
Fewer US adults suggested for statin therapy for primary prevention by new risk calculator
Fewer U.S. adults aged 40 to 75 years are eligible for statin therapy for primary CVD prevention in the new PREVENT risk calculator compared with the older Pooled Cohort Equation, researchers reported.
Speaker: ‘De-risk’ patients with high Lp(a) to prevent atherosclerotic events
PHILADELPHIA — Despite there being few options to directly lower lipoprotein(a) as of yet, measurement is none the less important to identify those who would benefit from improved risk factor control, a speaker reported.
Statins beneficial as primary CVD prevention in older adults, study suggests
Statins were associated with a reduced risk for CVD and death in older adults, even those aged 85 years and older, data in Annals of Internal Medicine showed.
Statin use linked to ‘sharp 86% risk reduction’ for primary sclerosing cholangitis in IBD
WASHINGTON — Statin use was associated with up to a 90% risk reduction for new-onset primary sclerosing cholangitis among patients with inflammatory bowel disease, according to data presented at Digestive Disease Week.